GlassScriptPhysician profile
Allison Beth Neal
NPI 1679076038
$3,047.53
in general payments reported to CMS, 2019-2025
39 companies · $18.99 in 2025
The $18.99 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $840 · 2022: $720 · 2023: $1,194 · 2024: $274 · 2025: $18.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,344 · Education: $144.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,343.64 |
| Education | $143.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $635.06 | 2021-2023 | Tezspire, Fasenra, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $273.78 | 2021-2023 | Stiolto Respimat, Spiriva Respimat, Ofev |
| Jazz Pharmaceuticals INC. | $259.68 | 2021-2024 | |
| Mylan Specialty L.P. | $134.43 | 2021-2024 | Yupelri |
| Glaxosmithkline, LLC. | $125.10 | 2021-2023 | Trelegy Ellipta |
| Actelion Pharmaceuticals US, INC. | $116.16 | 2021-2024 | Opsumit, Uptravi |
| Regeneron Healthcare Solutions, INC. | $107.36 | 2022-2024 | Dupixent |
| Mallinckrodt Hospital Products INC. | $107.05 | 2021-2023 | Acthar |
| Alexion Pharmaceuticals, INC. | $98.77 | 2024 | |
| Abiomed | $96.92 | 2021 | |
| Grifols USA, LLC | $86.90 | 2021-2024 | Prolastin-C Liquid |
| Philips North America LLC | $79.32 | 2022-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $77.94 | 2022-2023 | Glassia |
| Amgen INC. | $77.40 | 2022-2023 | Tezspire |
| United Therapeutics Corporation | $72.45 | 2021-2023 | Tyvaso |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $58.03 | 2021-2023 | |
| Baxter Healthcare | $54.62 | 2022-2023 | Hillrom - Vest System Model 205 Acute Care |
| Astellas Pharma US INC | $52.91 | 2021 | |
| Axsome Therapeutics, INC. | $51.21 | 2023-2024 | Sunosi |
| Pulmonx Corporation | $42.70 | 2022-2023 | Chartis Catheter, Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter |
| Pfizer INC. | $41.10 | 2022-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $37.49 | 2022 | |
| Harmony Biosciences LLC | $37.31 | 2022-2024 | |
| Alnylam Pharmaceuticals INC. | $33.53 | 2023 | Givlaari |
| Sunovion Pharmaceuticals INC. | $29.82 | 2021 | |
| Resmed Corp | $27.70 | 2023 | |
| Abbvie INC. | $23.16 | 2023 | |
| Inogen, INC. | $22.42 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Janssen Pharmaceuticals, INC | $20.67 | 2021 | |
| Ani Pharmaceuticals, INC. | $20.18 | 2024 | Purified Cortrophin Gel |
| Advanced Respiratory, INC | $20.00 | 2021 | |
| Solventum Corporation | $18.99 | 2025 | Promogran Prisma, 3m Cavilon, Activ.A.C. |
| Covis Pharma Gmbh | $17.89 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $17.77 | 2021 | |
| Inspire Medical Systems, INC. | $15.28 | 2023 | Inspire |
| Phadia US INC. | $15.24 | 2022 | |
| Ironshore Pharmaceuticals INC. | $14.50 | 2024 | |
| Teva Pharmaceuticals USA, INC. | $14.31 | 2022 | |
| Vanda Pharmaceuticals INC. | $12.38 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Neal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.